Skip to main content
. 2021 Nov 2;2021:8600443. doi: 10.1155/2021/8600443

Table 3.

Summary of symptoms and objective sleep by time point.

Variable Time 1 (N = 11) mean ± SD Time 2 (N = 11) mean ± SD Time 2–Time 1 (N = 11) mean ± SD p value
Depression
 CES-D 17.27 ± 11.42 12.00 ± 8.51 −5.27 ± 5.92 0.01 (0.03)
 Neuro-QOL depression SF 14.09 ± 7.73 10.82 ± 3.57 −3.27 ± 6.33 0.12 (0.11)

Anxiety
 GAD-7 5.45 ± 4.78 3.27 ± 4.29 −2.18 ± 2.40 0.01 (0.02)
 Neuro-QOL anxiety SF 14.55 ± 6.89 10.45 ± 4.01 −4.09 ± 4.68 0.02 (0.02)

Stress
 PSS 14.27 ± 7.55 9.64 ± 7.90 −4.64 ± 4.76 0.01 (0.01)

Objective sleep# Time 1 (N = 10) Time 2 (N = 9) Time 2–Time 1 (N = 9)
 Efficiency 93.67 ± 1.89 95.35 ± 2.38 1.81 ± 1.76 0.01 (0.02)
 TST 8.87 ± 2.08 9.26 ± 2.36 0.52 ± 2.73 0.58 (0.65)
 WASO 29.48 ± 8.58 21.00 ± 8.12 −9.34 ± 11.58 0.04 (0.04)
 Number of awakenings 9.12 ± 3.91 6.94 ± 2.91 −2.55 ± 3.41 0.06 (0.05)
 Length of awake time (minutes) 29.48 ± 8.58 21.00 ± 8.12 −9.34 ± 11.58 0.04 (0.04)

Derived from paired t-test (signed-rank test), #derived from actigraph using the Cole–Kripke analysis method [83]. CES-D = Center for Epidemiological Studies Depression Scale; GAD-7 = Generalized Anxiety Disorder 7-item Scale; PSS = Perceived Stress Scale; SF = Short Form; Bold shows statistically significant p-value, derived from paired t-test (signed-rank test). sleep efficiency = total sleep time/time in bed × 100; TST = total sleep time; WASO = wake after sleep onset; time 1 = preintervention; time 2 = postintervention.